GO:0005829; C:cytosol; IDA:UniProtKB
GO:0031012; C:extracellular matrix; IDA:UniProtKB
GO:0070062; C:extracellular vesicular exosome; IDA:UniProtKB
GO:0005794; C:Golgi apparatus; IDA:UniProtKB
GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB
GO:0016020; C:membrane; IDA:UniProtKB
GO:0045121; C:membrane raft; IDA:UniProtKB
GO:0005730; C:nucleolus; IDA:UniProtKB
GO:0005634; C:nucleus; IDA:UniProtKB
GO:0005886; C:plasma membrane; IDA:UniProtKB
GO:0005509; F:calcium ion binding; IDA:UniProtKB
GO:0042609; F:CD4 receptor binding; IPI:UniProtKB
GO:0003677; F:DNA binding; IEA:UniProtKB-KW
GO:0019899; F:enzyme binding; IPI:UniProtKB
GO:0005154; F:epidermal growth factor receptor binding; IPI:UniProtKB
GO:0017128; F:phospholipid scramblase activity; IDA:UniProtKB
GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
GO:0017124; F:SH3 domain binding; IDA:UniProtKB
GO:0006953; P:acute-phase response; ISS:UniProtKB
GO:0006915; P:apoptotic process; IDA:UniProtKB
GO:0051607; P:defense response to virus; IMP:UniProtKB
GO:0045071; P:negative regulation of viral genome replication; IMP:UniProtKB
GO:0006659; P:phosphatidylserine biosynthetic process; ISS:UniProtKB
GO:0017121; P:phospholipid scrambling; IDA:UniProtKB
GO:0030168; P:platelet activation; NAS:UniProtKB
GO:2000373; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; IDA:UniProtKB
GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB
GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
GO:0060368; P:regulation of Fc receptor mediated stimulatory signaling pathway; ISS:UniProtKB
GO:0033003; P:regulation of mast cell activation; ISS:UniProtKB
GO:0035456; P:response to interferon-beta; IMP:UniProtKB